类风湿关节炎与肠道通透性增加及细菌易位相关,且控制炎症后可逆转
在20例类风湿关节炎(RA)患者和20例年龄性别匹配对照的结肠活检中,RA患者紧密连接蛋白ZO-1表达低于对照;另一队列59例RA(21例未用DMARDs,其中17例在csDMARDs治疗前后;38例重症RA在bDMARDs治疗前后)和33例健康对照中,RA患者血清LBP和sCD14升高,且与DAS28相关;bDMARD应答者LBP和sCD14显著降低。
要点
- RA患者结肠ZO-1蛋白表达低于对照(平均评分1.6±0.56 vs 2.0±0.43,p=0.01)。
- RA患者血清LBP和sCD14高于对照,且与DAS28相关(r=0.61,p=0.005;r=0.57,p=0.01)。
- bDMARD应答者LBP和sCD14显著降低,非应答者和csDMARDs治疗者未降低。
核心结论
- RA患者结肠紧密连接蛋白改变,血清肠道通透性生物标志物升高。
- 肠道通透性血清标志物与疾病活动度及bDMARD应答相关。
- 这些结果提示RA中肠道完整性受损与全身炎症之间存在关联。
研究设计与样本
- 研究纳入20例RA患者和20例年龄性别匹配对照,用免疫组化定量结肠活检中ZO-1、occludin和claudin 2,由两名盲法独立阅片者评估染色强度。
- 另一队列纳入59例RA(21例未用DMARDs,其中17例在csDMARDs引入前后;38例重症RA在bDMARDs引入前后)和33例健康对照,用ELISA检测血清LBP、sCD14和zonulin相关蛋白(ZRP)。
主要发现
- RA患者结肠ZO-1蛋白表达低于对照(平均评分±SEM为1.6±0.56 vs 2.0±0.43;p=0.01),occludin和claudin-2无显著差异。
- RA患者血清LBP和sCD14浓度高于对照。
- LBP与DAS28相关(r=0.61,p=0.005),sCD14与DAS28相关(r=0.57,p=0.01),ZRP与DAS28不相关。
- bDMARD应答者LBP和sCD14浓度显著降低,bDMARD非应答者和csDMARDs治疗患者未降低。
关键数值与推荐
- RA患者vs对照:结肠ZO-1平均评分1.6±0.56 vs 2.0±0.43(p=0.01)。
- LBP与DAS28:r=0.61,p=0.005;sCD14与DAS28:r=0.57,p=0.01。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: to assess how rheumatoid arthritis (RA) and Disease Modifying Anti Rheumatic Drugs (DMARDs) affect gut permeability. METHODS: to explore colonic mucosa integrity, tight junction proteins ZO-1, occludin and claudin 2 were quantified by immunohistochemistry on colonic biopsies in 20 RA patients and 20 age- and sex-matched controls. Staining intensity was assessed by two blinded independent readers. To explore intestinal permeability, serum concentrations of LPS-binding protein (LBP), sCD14 and zonulin-related proteins (ZRP) were evaluated by ELISA in another cohort of 59 RA: 21 patients naive of DMARDs (17 before and after introduction of a conventional synthetic (cs) DMARDs), 38 patients with severe RA (before and after introduction of a biological (b) DMARDs), and 33 healthy controls. RESULTS: Z0-1 protein was less expressed in colon of RA patients than controls (mean score ± SEM of 1.6 ± 0.56 vs 2.0 ± 0.43; p= 0.01), while no significant difference was detected for occludin and claudin-2. RA patients had higher serum LBP and sCD14 concentrations than controls. LBP and sCD14 levels were significantly correlated with DAS28 (r = 0.61, p= 0.005 and r = 0.57, p= 0.01, respectively) while ZRP did not. bDMARD responders had significantly reduced LBP and sCD14 concentrations unlike bDMARDs non-responders and patients treated with csDMARDs. CONCLUSION: RA patients have altered colonic tight junction proteins and increased serum biomarkers of intestinal permeability. There was a correlation between serological markers of intestinal permeability and disease activity as well as bDMARD response. These results suggest a link between impaired gut integrity and systemic inflammation in RA.
引用
- Audo R, Sanchez P, Rivière B, et al. Rheumatoid arthritis is associated with increased gut permeability and bacterial translocation which are reversed by inflammation control. Rheumatology (Oxford). 2022. PMID: 35947472. doi:10.1093/rheumatology/keac454
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。